US 10328087
Formulations for solubilizing hormones
granted A61KA61K31/015A61K31/565
Quick answer
US patent 10328087 (Formulations for solubilizing hormones) held by Compass Therapeutics LLC expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/015, A61K31/565, A61K31/573, A61K47/06